Biologics Manufacturing Asia 2025
The 12th Annual Biologics Manufacturing Asia 2025 is APAC's premier bioprocessing conference, gathering industry leaders from across the region and globally. The event focuses on cutting-edge manufacturing technologies, single-use systems, process optimization, and emerging therapeutics including RNA and novel modalities. Industry experts will share insights on facility design, regulatory compliance, and cost-efficiency strategies. The conference is co-located with multiple events, including the 9th Biologistics World Asia, Clinical Trial Festival Asia, and the Asia-Pacific Bioprocessing Excellence Awards Gala Dinner 2025.
BioLogistics World Asia 2025
Join us at the 9th BioLogistics World Asia 2025 on March 12-13 at Marina Bay Sands, Singapore, where leaders in biopharma logistics come together to address the evolving challenges of transporting biological materials.
This event will delve into the latest strategies and technologies transforming cold chain logistics and strengthening supply chains in Asia's expanding biopharma market. With keynote presentations, panel discussions, and networking opportunities, attendees will explore innovations in cold chain logistics, ensuring the successful delivery of biologics, vaccines, and cell therapies across the region. Don’t miss your chance to shape the future of biopharma logistics in Asia!
Clinical Trials Festival Asia 2025
Join us at Clinical Trials Festival Asia 2025, the region's premier clinical research conference in its third year. Connect with industry leaders to explore innovations in trial design, management, and decentralized approaches, while discussing partnerships, regulations, and digital strategies. The event highlights Asia's growing role in clinical research, particularly in Singapore, South Korea, and Australia, offering valuable networking opportunities with diverse professionals to enhance trial efficiency across the region.
Biologics Digitalization & AI World 2025
The Digitalization and AI presence in the Global Biopharma Industry, valued at USD 1784.1 Million in 2022, is projected to reach $2.47 Billion by 2027, with a robust growth rate exceeding 5.7% from 2023 to 2030. This growth is particularly notable in the APAC region, where governments are offering strategic incentives for biomanufacturing and technology adoption. Following its successful inaugural edition, the Biologics Digitalization & AI World conference returns on March 12th and 13th, serving as a platform for Biologics sector leaders in APAC to showcase how their pioneering adoption of AI and digitalization across various aspects of BioPharma has improved process efficiency, enhanced productivity, reduced costs, and maintained top-tier quality.
ADC Asia Congress 2025